Startseite Estrogen-insensitivity syndrome (EIS) in a female adolescent patient – a case report
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Estrogen-insensitivity syndrome (EIS) in a female adolescent patient – a case report

  • Akbar Soltani , Mahdieh Fatollahzadeh , Pantea Izadi , Zahra Abbaspour Rad , Zahra Hoseini Tavassol , Hamid Pajavand , Masoomeh Amini und Shirin Hasani-Ranjbar EMAIL logo
Veröffentlicht/Copyright: 20. September 2024

Abstract

Objectives

Estrogen insensitivity syndrome (EIS) is a rare genetic disorder characterized by an autosomal dominant inheritance pattern. The disease results from a pathogenic variant in the ESR1 (estrogen receptor 1) gene, leading to estrogen resistance in individuals possessing the 46, XX karyotype. The alpha receptor, which is predominant in peripheral tissues, is responsible for estrogen action. As a result, pathogenic variants in the ESR1 gene can cause various disorders, such as changes in secondary sexual characteristics, increased concentrations of estrogen and gonadotropins, and delayed bone maturation.

Case presentation

Here, the case of a 13-year-old girl, with high estrogen and gonadotropin concentrations, lack of breast development, uterine growth and delayed bone age is described. The patient’s parents were related. She was found to have a homozygous pathogenic variant in the ESR1 gene located on chromosome 6q25, which interferes with estrogen signaling.

Conclusions

This case supports that disruption of ESR1 causes profound estrogen resistance in females.


Corresponding author: Shirin Hasani-Ranjbar, Obesity and Eating Habits Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran, E-mail:

Award Identifier / Grant number: 1401-3-221-62409

Acknowledgments

The authors are grateful to Dr. Ahmad Ebrahimi and GENIA medical genetics laboratory, Tehran, Iran. And we extend our gratitude to the patient and her family.

  1. Research ethics: This research study conformed to the Declaration of Helsinki principles and approved by Ethical Committee of Endocrinology and Metabolism Research Institute of Tehran University of Medical Sciences (ID number: IR.TUMS.EMRI.REC.1401.045).

  2. Informed consent: Informed written consent from the patient and her parents was obtained prior to inclusion in the study.

  3. Author contributions: Investigation and treatment – AS, SHR and MF; genetic analysis – PI, ZHT and MA; data curation – ZA; writing – original draft preparation – ZHT and HP; writing – review and editing – SHR. All authors have read and agreed to the published version of the manuscript.

  4. Use of Large Language Models, AI and Machine Learning Tools: None declared.

  5. Conflict of interest: Authors state no conflict of interest.

  6. Research funding: This study was funded by the Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran (Number: 1401-3-221-62409).

  7. Data availability: The original contributions presented in the study are included in the article; further inquiries can be directed to the corresponding author.

References

1. Bernard, V, Kherra, S, Francou, B, Fagart, J, Viengchareun, S, Guechot, J, et al.. Familial multiplicity of estrogen insensitivity associated with a loss-of-function ESR1 mutation. J Clin Endocrinol Metab 2017;102:93–9. https://doi.org/10.1210/jc.2016-2749.Suche in Google Scholar PubMed PubMed Central

2. Li, Y, Hamilton, KJ, Perera, L, Wang, T, Gruzdev, A, Jefferson, TB, et al.. ESR1 mutations associated with estrogen insensitivity syndrome change conformation of ligand-receptor complex and altered transcriptome profile. Endocrinology 2020;161:bqaa050. https://doi.org/10.1210/endocr/bqaa050.Suche in Google Scholar PubMed PubMed Central

3. Hamilton, KJ, Hewitt, SC, Arao, Y, Korach, KS. Estrogen hormone biology. Curr Top Dev Biol 2017;125:109–46. https://doi.org/10.1016/bs.ctdb.2016.12.005.Suche in Google Scholar PubMed PubMed Central

4. Farkas, S, Szabo, A, Hegyi, AE, Torok, B, Fazekas, CL, Ernszt, D, et al.. Estradiol and estrogen-like alternative therapies in use: the importance of the selective and non-classical actions. Biomedicines 2022;10:861. https://doi.org/10.3390/biomedicines10040861.Suche in Google Scholar PubMed PubMed Central

5. Smith, EP, Boyd, J, Frank, GR, Takahashi, H, Cohen, RM, Specker, B, et al.. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 1994;331:1056–61. https://doi.org/10.1056/nejm199410203311604.Suche in Google Scholar PubMed

6. Delcour, C, Khawaja, N, Gonzalez-Duque, S, Lebon, S, Talbi, A, Drira, L, et al.. Estrogen receptor alpha inactivation in 2 sisters: different phenotypic severities for the same pathogenic variant. J Clin Endocrinol Metab 2022;107:e2553–62.10.1210/clinem/dgac065Suche in Google Scholar PubMed

7. Charest, NJ, Zhou, ZX, Lubahn, DB, Olsen, KL, Wilson, EM, French, FS. A frameshift mutation destabilizes androgen receptor messenger RNA in the Tfm mouse. Mol Endocrinol 1991;5:573–81. https://doi.org/10.1210/mend-5-4-573.Suche in Google Scholar PubMed

8. Adegoke, TE, Sabinari, IW, Areola, ED, Ajao, F, Asafa, OO, Soluoku, TK, et al.. Inhibition of dipeptidyl peptidase-4 averts free fatty acids deposition in the hearts of oral estrogen-progestin contraceptive-induced hyperinsulinemic female rats. Can J Physiol Pharmacol 2021;99:1316–23. https://doi.org/10.1139/cjpp-2021-0043.Suche in Google Scholar PubMed

9. Quaynor, SD, Stradtman, EWJr, Kim, HG, Shen, Y, Chorich, LP, Schreihofer, DA, et al.. Delayed puberty and estrogen resistance in a woman with estrogen receptor alpha variant. N Engl J Med 2013;369:164–71. https://doi.org/10.1056/nejmoa1303611.Suche in Google Scholar PubMed PubMed Central

10. Moenter, SM, Silveira, MA, Wang, L, Adams, C. Central aspects of systemic oestradiol negative- and positive-feedback on the reproductive neuroendocrine system. J Neuroendocrinol 2020;32:e12724. https://doi.org/10.1111/jne.12724.Suche in Google Scholar PubMed PubMed Central

11. Brakta, S, Chorich, LP, Kim, HG, Coons, LA, Katzenellenbogen, JA, Hall, JE, et al.. Long-term follow-up and treatment of a female with complete estrogen insensitivity. J Clin Endocrinol Metab 2020;105:1478–88. https://doi.org/10.1210/clinem/dgaa106.Suche in Google Scholar PubMed PubMed Central

12. Clusan, L, Ferriere, F, Flouriot, G, Pakdel, F. A basic review on estrogen receptor signaling pathways in breast cancer. Int J Mol Sci 2023;24:6834. https://doi.org/10.3390/ijms24076834.Suche in Google Scholar PubMed PubMed Central

13. Saito, K, Cui, H. Estrogen receptor alpha splice variants, post-translational modifications, and their physiological functions. Cells 2023;12:895. https://doi.org/10.3390/cells12060895.Suche in Google Scholar PubMed PubMed Central

14. Karlafti, E, Lampropoulou-Adamidou, K, Tournis, S, Trovas, G, Triantafyllopoulos, IK. Effect of estrogen on bone cells: what is new? JRPMS 2019;3:113–22. https://doi.org/10.22540/jrpms-03-113.Suche in Google Scholar

15. Li, Y, Zhai, Y, Li, L, Lu, Y, Su, S, Liu, Y, et al.. Divergent associations between serum androgens and ovarian reserve markers revealed in patients with polycystic ovary syndrome. Front Endocrinol 2022;13. https://doi.org/10.3389/fendo.2022.881740.Suche in Google Scholar PubMed PubMed Central

Received: 2024-04-14
Accepted: 2024-09-04
Published Online: 2024-09-20
Published in Print: 2024-11-26

© 2024 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Review
  3. Selecting optimal progestational agents either alone or in combination in common pediatric endocrine settings: challenges of unmet needs
  4. Original Articles
  5. Comparison of the effectiveness of prepubertal growth hormone treatment on height and predicted adult height in children with short stature born small for gestational age vs. with a growth hormone deficiency
  6. Expanded phenotypic spectrum in MODY 5 patients with 17q12 deletion syndrome: experience from an Indian tertiary care hospital
  7. Endocrine sequelae after pediatric craniopharyngioma treatment: a single-center retrospective cohort study
  8. Premature ovarian insufficiency in pediatric cancer patients: a 10 year Rady Children’s Hospital experience
  9. Alterations in optical coherence tomography and optical coherence tomography angiography findings in children with partial biotinidase deficiency
  10. Slow growth and short stature in children with attention deficit hyperactivity disorder (ADHD): a retrospective study of 493 children who underwent growth hormone provocation testing at one tertiary paediatric endocrine centre
  11. Short Communication
  12. Assessment of diabetes-specific knowledge and its determinants among children with type 1 diabetes mellitus and their primary caregivers: Experience from a tertiary care center in North India
  13. Letters to the Editor
  14. Comment on “Diagnostic utility of the average peak LH levels measured during GnRH stimulation test”
  15. Author’s reply “Comment on diagnostic utility of the average peak LH levels measured during GnRH stimulation test”
  16. Case Reports
  17. Estrogen-insensitivity syndrome (EIS) in a female adolescent patient – a case report
  18. The complexities of managing a newborn with 6q24 transient neonatal diabetes mellitus: a case report
  19. Homozygous mutation of KISS1 receptor (KISS1R) gene identified in a Chinese patient with congenital hypogonadotropic hypogonadism (CHH): case report and literature review
  20. Selpercatinib prior to radioactive iodine for pediatric papillary thyroid carcinoma
Heruntergeladen am 9.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2024-0176/html
Button zum nach oben scrollen